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G12 8TA, UK
1The Queen’s Medical Research Institute, Centre for Cardiovascular Science, 47 Little France Crescent, Edinburgh EH16 4TJ, UK
(Correspondence should be addressed to E Davies; Email: ed18g@clinmed.gla.ac.uk)AbstractUsing a highly sensitive quantitative RT-PCRmethod for the
measurement of CYP11B1 (11b-hydroxylase) and CYP11B2
(aldosterone synthase) mRNAs, we previously demonstrated
thatCYP11B2 expression in the central nervous system (CNS)
is subject to regulation by dietary sodium. We have now
quantified the expression of these genes in the CNS of male
Wistar Kyoto (WKY) rats in response to systemic ACTH
infusion, dexamethasone infusion, and to adrenalectomy.
CYP11B1 and CYP11B2 mRNA levels were measured in
total RNA isolated from the adrenal gland and discrete brain
regions using real-time quantitative RT-PCR. ACTH
infusion (40 ng/day for 7 days, NZ8) significantly increased
CYP11B1 mRNA in the adrenal gland, hypothalamus, and
cerebral cortex compared with animals infused with vehicleThis is an Open Access article distributed under the terms of the Society for Endo
distribution, and reproduction in any medium, provided the original work is prop
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0022–0795/08/0196–305 q 2008 Society for Endocrinology Printed in Greatonly. ACTH infusion decreased adrenal CYP11B2 expression
but increased expression in all of the CNS regions except the
cortex. Dexamethasone (10 mg/day for 7 days,NZ8) reduced
adrenalCYP11B1mRNA compared with control animals but
had no significant effect on either gene’s expression in the
CNS.Adrenalectomy (NZ6 per group) significantly increased
CYP11B1 expression in the hippocampus and hypothalamus
and raised CYP11B2 expression in the cerebellum relative to
sham-operated animals. This study confirms the transcription
of CYP11B1 and CYP11B2 throughout the CNS and
demonstrates that gene transcription is subject to differential
regulation by ACTH and circulating corticosteroid levels.
Journal of Endocrinology (2008) 196, 305–311Introduction
Corticosteroid hormones such as aldosterone and corticos-
terone are synthesized by specific enzymes in the adrenal
cortex but now there is strong evidence that these enzymes
are also present in other tissues (Davies & MacKenzie 2003).
Although these extra-adrenal sites are not capable of
corticosteroid production on the same scale as the adrenal
cortex, due to a much lower level of relevant gene expression,
their proximity to glucocorticoid receptors (GR) and
mineralocorticoid receptors (MR) is consistent with a
paracrine/autocrine mode of steroid hormone action. We
and others have shown that the brain is a major extra-adrenal
site of corticosteroid production (Gomez-Sanchez et al. 1997,
MacKenzie et al. 2000a). The genes for all of the enzymes
required to form aldosterone and corticosterone de novo from
cholesterol are transcribed, including those of such early
pathway enzymes as the steroidogenic acute regulatory
protein, the side-chain cleavage enzyme (P450scc), and
3b-hydroxysteroid dehydrogenase (3b-HSD; Furukawa
et al. 1998). Furthermore, we have shown that the enzymesthat perform the terminal stages of corticosteroid biosyn-
thesis, aldosterone synthase, and 11b-hydroxylase are
themselves present in rat brain (MacKenzie et al. 2000a).
These studies showed expression of all these genes to occur in
areas throughout the brain, with expression strongest within
the hippocampus and dentate gyrus as well as the cerebellar
granule layer and Purkinje cells.
In the rat, 11b-hydroxylase (CYP11B1) and aldosterone
synthase (CY11B2) convert 11-deoxycorticosterone (DOC)
to corticosterone and aldosterone respectively. Their genes,
CYP11B1 and CYP11B2, possess highly homologous coding
regions but differ markedly in their regulation. In the adrenal
cortex, CYP11B1 expression is controlled by adrenocortico-
trophin (ACTH) while CYP11B2 is regulated mainly by the
renin-angiotensin system. In the adrenal cortex, the expression
of these genes is subject to strict zonation: CYP11B2 is
confined to the zona glomerulosa and CYP11B1 to the
zona fasciculata/reticularis. ACTH increases CYP11B2
expression acutely but long-term administration of high
doses results in regression of the zona glomerulosa and
the consequent suppression of aldosterone synthase expressioncrinology’s Re-use Licence which permits unrestricted non-commercial use,
erly cited.
DOI: 10.1677/JOE-07-0439
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ofCYP11B1 andCYP11B2 expression appears to be identical,
so that the two enzymes are present within the same cells,
such as the cerebellar granule layer and Purkinje cells
(MacKenzie et al. 2000a).
We previously developed a quantitativeRT-PCRmethod for
accurate, sensitive measurement of CYP11B1 and CYP11B2
mRNA in brain tissue. The detection limit of 100 copies/mg
total RNA permitted the detection of both CYP11B1 and
CYP11B2 transcription throughout the rat brain and revealed
that local CYP11B2 transcription increases in response to
dietary sodium restriction (Ye et al. 2003). Furthermore,
although the presence of CYP11B2 transcripts was clearly
demonstrable in brain stem, cerebral cortex, hippocampus,
hypothalamus, and cerebellum, CYP11B2 expression only
responded to dietary sodium restriction in the hippocampus and
the cerebellum, suggesting that regulationmay vary throughout
the brain.
The aimof this studywas to extend our previous observations
by comparing and contrasting the effects of systemic infusion of
ACTH and dexamethasone on CYP11B1 and CYP11B2
expression in the adrenal gland and central nervous system
(CNS). In addition, the effect of adrenalectomy on central
CYP11B1 and CYP11B2 expression was also studied.Materials and Methods
Experimental animals
The authors confirm that all animal experimentation
described in this paper was conducted in accord with
accepted standards of humane animal care and UK legal
requirements.ACTH and dexamethasone infusion
Three groups of adult male Wistar rats (250–300 g, NZ8),
fed on normal chow (Special Diet Services Ltd, Witham,
Essex, UK), were infused with normal saline vehicle, ACTH
(40 ng/day) or dexamethasone (10 mg/day) via Alzet osmotic
minipumps model 2002 (pump rate 0.5 ml/h, Alzet osmotic
minipumps, Cupertino, CA, USA) for 7 days. Blood pressure
was recorded by tail cuff plethysmography and rats were
weighed before and at the end of treatment.Adrenalectomy and tissue collection
Adrenal glands were removed from 12-week-old male WKY
rats (NZ6). Another group of six animals was subjected to
sham operation as a control. Post-operation, the animals were
maintained for 7 days on normal chow (Special Diet Services
Ltd) and were given 0.154 M sodium chloride to drink.
On completion of experiments, the animals were killed
by decapitation and trunk blood was collected for the assay
of plasma renin activity (PRA). The adrenal glands,Journal of Endocrinology (2008) 196, 305–311hippocampus, cerebellum, hypothalamus, brain stem, and
cerebral cortex were removed, cleaned, weighed, and frozen
at K70 8C for RNA isolation.Plasma and fecal analyses
PRA and steroid concentration were measured as previously
described (Ye et al. 2005). Fecal steroids were measured by a
modified version of the method of Pihl & Hau (2003). Briefly,
fecal pellets were collected daily into preweighed 50 or 100 ml
tubes and stored at K20 8C until analyzed. Each 24 h sample
was homogenized by a hand-held disperser, Ultra-Turrax T8
(IKA Werke GmbH & Co. KG, Janke & Kunkel Str. 10,
D-79219 Staufen, Germany) in four volumes of H2O.
Approximately 1 g of homogenate was extracted twice with
five volumes of dichloromethane (CH2Cl2) and then washed
once with one volume of NaOH (0.1 M) and twice with one
volumeof dH2O.The dichloromethane extract was dried down
under a stream of nitrogen and reconstituted in assay buffer.
Corticosterone (B) and aldosterone were measured by RIA.Total RNA isolation
Tissues were homogenized using a RiboLyzer cell disruptor
(Hybaid, Middlesex, UK) and total tissue RNA was isolated
using RNABee (200 mg/ml; Biogenesis, Poole, UK). RNA
was treated with DNase (DNA-free, Ambion, Austin, TX,
USA) and its quality was confirmed by electrophoresis on
agarose gels. RNA concentration was measured using the
RiboGreen RNAQuantitation Kit (Molecular Probes, Leiden
The Netherlands) and a Wallac Victor2 1420 Multilabel
Counter (Perkin–Elmer, Waltham, MA, USA).Real-time quantitative reverse transcriptase-PCR (qRT-PCR)
CYP11B1 and CYP11B2mRNA levels were measured using
the Roche LightCycler and external homologous RNA
standards as previously described (Ye et al. 2003). The lower
limit of detection of each assay was 100 copies/mg total RNA.
Each qRT-PCR run consisted of up to 45 PCR cycles;
adrenal and brain sample crossing points were all in the range
of 15–36 cycles. The intra- and inter-assay coefficients of
variation of each assay, calculated using the RT-PCR crossing
point, was !5%.Data analysis
ACTH infusion increased adrenal weight significantly. This
was presumably mainly due to zona fasciculata hypertrophy
and hyperplasia. The calculated CYP11B1 copy numbers for
the infusion experiments were therefore corrected for
changes in tissue mass. The mRNA quantities are presented
both as uncorrected and as copy number/mg total RNA/g
fresh tissue weight. Zona glomerulosa volume would be
expected to decrease but it was not possible to quantify this
accurately. Therefore, adrenal CYP11B2 mRNA expressionwww.endocrinology-journals.org
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expressed per unit weight of tissue.
Data were analyzed by ANOVA or by Kruskal–Wallis
ANOVA on ranks, when data were not normally distributed
or variance was different between groups. Differences
between specific mean pairs were analyzed by Tukey’s test
for multiple comparisons or by the Holm–Sidak method. For
all analyses, P!0.05 was required for statistical significance.
Data are expressed as the meanGS.E.M.Results
Effects of ACTH and dexamethasone infusion
ACTH infusion significantly decreased body weight
(P!0.01) and increased blood pressure (P!0.01) and adrenal
gland weight (P!0.01) at the time of killing, relative to
vehicle animals (Table 1). PRA in the ACTH-treated animals
was reduced to almost undetectable levels (P!0.05). In
ACTH-treated animals, plasma aldosterone and cortico-
sterone were increased relative to vehicle animals (P!0.01,
Table 1), similar to fecal corticosterone and aldosterone levels
(P!0.001, Fig. 1a and b).
Dexamethasone infusion reduced body weight (P!0.05)
and increased blood pressure (P!0.05) relative to vehicle
animals, but had no effect on adrenal gland weight (Table 1).
Dexamethasone infusion significantly suppressed fecal corti-
costerone levels (P!0.001, Fig. 1a). Although there was a
trend towards an increase in PRA with dexamethasone, this
was not statistically significant (Table 1).
Table 2 summarizes changes in adrenal gene expression
rates. ACTH infusion increased CYP11B1 mRNA copy
number in adrenal glands (P!0.05), but only when
correction was made for increased adrenal weight. ACTH
decreased CYP11B2 copy number (P!0.01). Dexametha-
sone infusion decreased CYP11B1 mRNA, both corrected
and uncorrected (P!0.05), relative to vehicle-infused
animals but had no significant effect on CYP11B2 mRNA.Table 1 Blood pressures, weights, renin activities, and plasma corticoste
treated animals
Vehicle (nZ8)
Initial blood pressure (mmHg) 124.1G2.9
Final blood pressure (mmHg) 134.8G3.7
DBlood pressure (mmHg) 10.7G3.8
Initial body weight (g) 294.5G4.6
Final body weight (g) 332.0G5.0
DBody weight (g) 37.4G3.9
Final adrenal weight (mg) 68.3G3.1
PRA (ng AI/ml per min) 0.29G0.11
Plasma aldosterone (pM) 117G65
Plasma corticosterone (nM) 285G157
*P!0.05 relative to vehicle; †P!0.01 relative to vehicle.
www.endocrinology-journals.orgExpression ofCYP11B1 and CYP11B2mRNA in the brain
are summarized in Fig. 2a and b. ACTH infusion increased
CYP11B1 copy number in the hypothalamus (P!0.05) and
cerebral cortex (P!0.05) relative to vehicle. It also increased
CYP11B2 copy number in the hippocampus, cerebellum,
hypothalamus, and brain stem (all P!0.05). The magnitude of
the increase in CYP11B1 and CYP11B2 copy numbers was
200–300%. Dexamethasone treatment had no significant effect
onCYP11B1orCYP11B2 expression in any regionof thebrain.Effects of adrenalectomy
Fecal aldosterone and corticosterone were significantly reduced
in adrenalectomized animals (both P!0.01), confirming the
success of the procedure (Fig. 3a and b). Adrenalectomy
increasedCYP11B1 expression in the hypothalamus (P!0.05)
and hippocampus (P!0.05), and increased CYP11B2
expression in the cerebellum (Fig. 4a and b), although the
magnitude of the effect was much smaller with 20–25% increase
in copy number.Discussion
These results confirm the widespread expression ofCYP11B1
and CYP11B2 transcripts in the brain. Although the levels of
mRNA are several orders of magnitude lower than those seen
in the adrenal gland and their abundance varies significantly
throughout the rat brain, central CYP11B1 and CYP11B2
expression are subject to transcriptional regulation.
Three experimental manipulations were used in order to
examine this regulation: (i) systemic infusion of ACTHwhich
mimics stress-induced hypothalamo-pituitary axis (HPA)
activation; (ii) suppression of ACTH by infusion of
dexamethasone; and (iii) elimination of adrenal corticoster-
oids through adrenalectomy.
The effects of these treatments on the adrenal gland were
largely predictable. ACTH infusion significantly increased
blood pressure, adrenal weight, and the fecal levels of
corticosterone. Adrenal CYP11B1 transcript numberroids of vehicle, dexamethasone- and adrenocorticotrophin (ACTH)
ACTH (nZ8) Dexamethasone (nZ8)
120.5G3.0 132.0G3.3
176.5G6.9 152.5G5.5†
56.0G6.7† 20.5G4.7*
302.1G6.0 284.8G3.7
287.5G9.2 310.2G6.8
K14.6G5.7† 25.3G5.6*
231.7G28.2† 68.3G9.5
0.03G0.02* 0.78G0.20
975G126† 412G166
3539G680† 200G77
Journal of Endocrinology (2008) 196, 305–311
Figure 1 (a and b) Effect of ACTH and dexamethasone infusion on
fecal corticosterone and aldosterone production.
P YE and others . Regulation of CYP11B1 and CYP11B2 in rat CNS308increased significantly after correction for the increased
adrenal mass, which was predominantly zona fasciculata.
This is in agreement with a previous study which also found
no overall adrenal response to ACTH unless adrenal growth
was taken into account (Holland & Carr 1993). While it is
possible that ACTH stimulates CYP11B1 transcription
acutely within each zona fasciculata cell over 7 days ACTH
also causes zona fasciculata cell proliferation (Mitani et al.
1996), thereby reducing the expression rate required of each
individual cell and probably explaining why we saw only a
proportionate increase in CYP11B1 mRNA after adrenal
mass was taken into account.
Chronic ACTH infusion increased fecal and plasma
aldosterone levels while decreasing CYP11B2 transcript levels
in the adrenal gland. Our steroid measurements are in contrast
to those from other studies that showed aldosterone to rise
sharply after ACTH administration but then gradually
decrease over time. However, the present study used lower
concentrations of ACTH and we have verified that our results
are not attributable to cross-reactivity of the RIA antibodyTable 2 Effect of adrenocorticotrophin (ACTH) and dexamethasone infu
Adrenal CYP11B1
n Copies/mg Copies/mg!adre
ACTH 7 3.0!108G0.3!108 6.9!107G0.4!
Dex 7 1.4!108G0.3!108* 0.9!107G0.3!
Vehicle 7 2.8!108G0.4!108 1.9!107G0.4!
*P!0.05; †P!0.01.
Journal of Endocrinology (2008) 196, 305–311with other steroids likely to be increased by ACTH, as has
been suggested in other studies (Abayasekara et al. 1993).
ACTH excess is known to reduce zona glomerulosa mass
but this is difficult to quantify (Mazzocchi et al. 1986, Mitani
et al. 1996). Therefore, it is likely that the apparent reduction
in CYP11B2 expression is due in part to a lower proportion
of zona glomerulosa-derived RNA relative to zona fascicu-
lata-derived RNA in ACTH-treated animals. Purification of
RNA from isolated adrenal capsules may have given a clearer
indication of zona glomerulosa CYP11B2 expression.
In the CNS, ACTH increased CYP11B1 expression in the
hypothalamus and cerebral cortex. It is possible that this subserves
a need for altered local glucocorticoid provision in these regions
or that expression is controlled differently in other regions.
ACTHsignificantly increasedCYP11B2mRNAlevels in almost
all of the brain regions we studied. ACTH acts through the
various forms of the melanocortin (MC) receptor and, although
the adrenal form, MC2, has not been detected in the adult rat
brain, there is evidence for the expression of MC3, MC4, and
MC5 throughout the brain, including areas of brain stem, cortex,
amygdala, hippocampus, and cerebellum (reviewed in Adan &
Gispen 1997). However, it is not immediately clear how
systemically administered ACTH could influence brain function
as the blood–brain barrier is assumed to be impermeable to
peptides. Some studies suggest that the circumventricular organs,
which lack a blood–brain barrier, play an important role in
conveying blood-borne substances and may provide a port for
peptide access (Kastin et al. 1984, Banks et al. 1993,Chikhale et al.
1994, Ganong 2000). Alternatively, ACTH-induced stimulation
of 11b-hydroxylase may raise circulating levels of DOC and
corticosterone, which can enter the brain and act as substrates for
aldosterone synthase (MacKenzie et al. 2000a).
Dexamethasone had no significant effect on CYP11B1 or
CYP11B2 transcription in the brain. Dexamethasone
suppresses adrenal corticosterone production which is
expected to lead to reduced occupancy of the brain MR.
However, this so-called hypocorticoid brain state does not
appear to influence central expression. Dexamethasone is
known to be excluded from the brain by P-glycoproteins in
all but the very highest amounts (Karssen et al. 2001). As the
dosage administered here was not excessive, it is doubtful that
sufficient dexamethasone entered the brain to influence local
CYP11B1 expression directly.
In the adrenalectomy studies, the success of the surgery was
confirmed by the low post-operative corticosterone levels.sion on adrenal CYP11B1 and CYP11B2 mRNA levels
Adrenal CYP11B2
nal weight (g) Copies/mg Adrenal weight (g)
107* 0.5!106G0.1!106† 0.231G0.028
107* 7.9!107G11.0!106 0.068G0.009
107 7.5!107G13.0!106 0.068G0.003
www.endocrinology-journals.org
Figure 2 (a and b) Effect of ACTH and dexamethasone infusion on
central CYP11B1 and CYP11B2 mRNA levels. *P!0.05; **P!0.01.
Figure 3 (a and b) Effect of adrenalectomy (ADX) on fecal
corticosterone and aldosterone production.
Regulation of CYP11B1 and CYP11B2 in rat CNS . P YE and others 309Extra-adrenal production of corticosterone from intestinal and
possibly other tissues might account for the extremely low but
nonetheless detectable levels of fecal steroid (Mueller et al.
2007). Adrenalectomy caused small but significant increases in
CYP11B1mRNA levels in the hippocampus andhypothalamus
and CYP11B2 mRNA levels in the cerebellum. It is expected
that adrenalectomy would result in increased plasma levels of
ACTH.However, these effects are clearly different from those of
ACTH infusion in both their region specificity and the
magnitude of response. The overall lack of change in
CYP11B2 expression may be due to the provision of saline
following surgery, which would maintain normal PRA and
angiotensin II, although these were not measured. However, as
with dexamethasone, it seems apparent that induction of a
hypocorticoid state has a lesser effect on the CYP11B1 and
CYP11B2 expression in the CNS.
When analyzing levels of mRNAwithin a tissue, studies are
open to the criticism that variations in transcription may notwww.endocrinology-journals.orgfeed through to differences in enzyme level, or that the real
limiting factor in the pathway may lie elsewhere. An elegant
study by Gomez-Sanchez et al. (2005) demonstrated that
providing DOC to adrenalectomized rats did not result in any
detectable levels of brain corticosterone; the authors logically
took this as an indication that levels of 11b-hydroxylase, and not
substrate, was the factor limiting corticosterone production in
these animals. However, if local corticosteroid biosynthesis is a
real phenomenon within the CNS, that study did raise the
question of why no corticosterone could be detected at all,
rather than simply a reduction relative to the intact animals. We
suspect that the reason the authors could not see any
corticosterone following adrenalectomy was twofold. First,
the low local production of steroid within discrete brain regions
will be further diluted when analyzed in a whole brain extract
consisting of expressing and non-expressing cells, such as that
employed by Go`mez-Sa´nchez et al. Second, our studies on
the brain tend to suggest that aldosterone synthase and
11b-hydroxylase are co-expressed within the brain. Since
both enzymes have a common substrate, DOC, and any
corticosterone produced by 11b-hydroxylase is a potential
substrate for aldosterone synthase, thenonemight expect to see a
more significant rise in aldosterone which was detected by
Go`mez-Sa´nchez et al. in the brains of adrenalectomized rats. It
further follows that there will be marked regional variation in
brain tissue levels of aldosterone and corticosterone if output is
related to the relative ratios of these two enzymes.
This study confirms the differential expression of CYP11B1
andCYP11B2 genes invarious regions of theCNS and supportsJournal of Endocrinology (2008) 196, 305–311
Figure 4 (a and b) Effect of adrenalectomy (ADX) on central
CYP11B1 and CYP11B2 mRNA levels. *P!0.05.
P YE and others . Regulation of CYP11B1 and CYP11B2 in rat CNS310a wealth of immunocytochemical and biochemical evidence
that aldosterone and corticosterone can be synthesized de novo
from cholesterol in the CNS (Gomez-Sanchez et al. 1996, 1997,
MacKenzie et al. 2000a,b).Although the levels of gene expression
and the steroidogenic capacity are much lower than those of the
adrenal gland (Gomez-Sanchez et al. 1997, Ye et al. 2003), the
presence ofMR andGR in the immediate vicinitymay facilitate
autocrine- or paracrine-mediated physiological effects.
What might these effects be? GR are widely distributed
throughout the brain and are associated with a range of
functions. For example, appetite and cognitive function are
controlled by GR, which is expressed at high levels in the
hypothalamus and hippocampus respectively, and both of these
areas mediate feedback control of the HPA axis. Although all
CNS regions that we examined express CYP11B1, it is
significant that the lowest levels of transcription are associated
with the hypothalamus and hippocampus. Arguably, this
mitigates against the importance of local CYP11B1Journal of Endocrinology (2008) 196, 305–311transcription in brain glucocorticoid action. However, as
previous immunocytochemical studies of 11-hydroxylase
indicate that expression is localized to particular cell types
within a region, it follows that the CYP11B1 levels that we
report may be diluted by RNA from the majority of non-
expressing cells. The expression of CYP11B1 is highest in the
cortex and brain stem. In the brain stem, GR is present in the
nerve cells nuclei associated with norepinephrine, epinephrine,
and serotonin. The subcellular translocation of GR from
cytoplasm to nucleus takes place after receptor activation and
might therefore indicate that cells are tonically exposed to high
levels of glucocorticoid hormonewhich, theoretically, could be
supplied autonomously by local 11b-hydroxylase activity.
MR is found in high concentrations in the hippocampus,
septum, and in some brain stem nuclei and is associated with the
regulation of fluid homeostasis through effects on thirst and salt
appetite. Central actions of aldosterone have been proposed to
play a role in blood pressure homeostasis. In this respect,
intracerebroventricular (ICV) administration of systemically
ineffective levels of aldosterone significantly increases blood
pressure (Gomez-Sanchez 1986). Whether modulation of
blood pressure is mediated by locally synthesized aldosterone
is unclear. However, ICVadministration of 19-ethynyl-DOC,
an inhibitor of aldosterone synthase, prevents the increase in
blood pressure following sodium treatment in the Dahl salt-
sensitive rat suggesting that locally synthesized aldosterone may
be important (Gomez-Sanchez et al. 1996).
How aldosterone mediates these central effects is unclear.
The enzyme 11b-HSD2 which inactivates corticosterone and
protects the MR from occupation by glucocorticoids is only
expressed in the subcommissural organ and nucleus tract
solitarius (Robson et al. 1998). This means that the vastmajority
of brain MR is non-selective for mineralocorticoid and
glucocorticoid. However, the hypertensive response to ICV
aldosterone can be inhibited by MR blockade, suggesting that
mineralocorticoids can access the MR even in the absence of
11b-HSD2. It is possible that ICVadministration of aldosterone
generates a high local concentration of steroid, allowing it
to compete on more equal terms with glucocorticoid for MR
occupancy. In this way, aldosterone could occupy sufficient
MR in order to generate a specific mineralocorticoid response.
Extra-adrenal aldosterone biosynthesis could be a way of
generating similar localized, high concentrations of mineralo-
corticoid within specific brain regions.
We have previously shown that the CYP11B2 gene is
expressed in specific cell types within discrete brain regions and
that its transcription is regulated by angiotensin II and sodium
(MacKenzie et al. 2002). Using different stimuli, this study
confirms that bothCYP11B1 andCYP11B2 gene expression in
the CNS can be regulated, suggesting a biological role for
11b-hydroxylase and aldosterone synthase within the CNS.
While the central role of these enzymes remains largely
unknown, this work represents important progress in the
elucidation of this complex system and demonstrates the need
for further detailed physiological studies.www.endocrinology-journals.org
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